The DOI matches its Crossref record; 3,517 of the 3,517 references it cites were found in a registry or an index.
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 2,001–2,200 of 3,517
Renard, C. E., Fiocco, A. J., Clénet, F., Hascoët, M., & Bourin, M. (2001) · Psychopharmacology · doi:10.1007/s002130100836 · Cited by 103
Ebner, K., Wotjak, C. T., Landgraf, R., & Engelmann, M. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01869.x · Cited by 103
Hervás, I., Queiroz, C. M., Adell, A., & Artigas, F. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703297 · Cited by 103
Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice
Smith, D. G., Tzavara, E. T., Shaw, J., Luecke, S., Wade, M., Davis, R., Salhoff, C., Nomikos, G. G., & Gehlert, D. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4079-04.2005 · Cited by 103
Interaction between estrogens and antidepressants in the forced swimming test in rats
Estrada-Camarena, E. M., Fernández‐Guasti, A., & López‐Rubalcava, C. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1707-4 · Cited by 103
Hsieh, G. C., Hollingsworth, P. R., Martino, B. R., Chang, R., Terranova, M. A., O'Neill, A. B., Lynch, J. J., Moreland, R. B., Donnelly‐Roberts, D. L., Kolasa, T., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.057455 · Cited by 103
Manber, R., Rush, A. J., Thase, M. E., Arnow, B., Klein, D., Trivedi, M. H., Korenstein, S. G., Markowitz, J. C., Dunner, D. L., Munsaka, M., et al. (2003) · SLEEP · doi:10.1093/sleep/26.2.130 · Cited by 102
Bupropion Treatment for Cocaine Abuse and Adult Attention-Deficit/Hyperactivity Disorder
Levin, F. R., Evans, S. M., McDowell, D. M., Brooks, D. J., & Nunes, E. (2002) · Journal of Addictive Diseases · doi:10.1300/j069v21n02_01 · Cited by 102
Hindmarch, I., Shamsi, Z., Stanley, N., & Fairweather, D. B. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00993.x · Cited by 102
Treatment Augmentation With Opiates in Severe and Refractory Major Depression
Stoll, A. L., & Rueter, S. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.2017 · Cited by 102
Comorbidity in primary care: presentation and consequences.
Wïttchen, H., Lieb, R., Wunderlich, U., & Schuster, P. (1999) · PubMed · Cited by 102
Complex phenotypic assays in high-throughput screening
Clemons, P. A. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.002 · Cited by 102
Dwivedi, Y., Mondal, A. C., Payappagoudar, G. V., & Rizavi, H. S. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.10.004 · Cited by 102
Protein Complexes Involved in Heptahelical Receptor-Mediated Signal Transduction
Rebois, R. V., & Hébert, T. E. (2003) · Receptors and Channels · doi:10.1080/10606820308243 · Cited by 102
Estimating rates of alternative splicing in mammals and invertebrates
Kim, H., Klein, R. J., Majewski, J., & Ott, J. (2004) · Nature Genetics · doi:10.1038/ng0904-915 · Cited by 102
The Biochemical and Neurologic Basis for the Treatment of Male Erectile Dysfunction
Moreland, R. B., Hsieh, G. C., Nakane, M., & Brioni, J. D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38739-7 · Cited by 101
Misane, I., & Ögren, S. O. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300024 · Cited by 101
Pramipexole in treatment-resistant depression: An extended follow-up
Cassano, P., Lattanzi, L., Soldani, F., Navari, S., Battistini, G., Gemignani, A., & Cassano, G. B. (2004) · Depression and Anxiety · doi:10.1002/da.20038 · Cited by 101
Stimulatory Effect of Melanin-Concentrating Hormone on Luteinising Hormone Release
González, M. I., Baker, B. I., & Wilson, C. A. (2008) · Neuroendocrinology · doi:10.1159/000127246 · Cited by 101
Selection and gene duplication: a view from the genome.
Wagner, A. (2002) · Genome biology · doi:10.1186/gb-2002-3-5-reviews1012 · Cited by 101
Nikisch, G., Ågren, H., Eap, C., Czernik, A., Baumann, P., & Mathé, A. (2005) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005158 · Cited by 101
Kenny, P. J., File, S. E., & Neal, M. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752409.x · Cited by 100
Sirviö, J., & MacDonald, E. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00017-0 · Cited by 100
Vázquez-Palacios, G., Bonilla‐Jaime, H., & Velázquez‐Moctezuma, J. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.03.002 · Cited by 100
Wu, X., Zhu, D., Jiang, X., Okagaki, P., Mearow, K. M., Zhu, G., McCall, S. A., Banaudha, K. K., Lipsky, R. H., & Marini, A. M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02526.x · Cited by 100
Human Cytochromes and Some Newer Antidepressants: Kinetics, Metabolism, and Drug Interactions
Greenblatt, D. J., Moltke, L. L., Harmatz, J. S., et al. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910001-00003 · Cited by 100
G protein signaling and the molecular basis of antidepressant action
Donati, R. J., & Rasenick, M. M. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00249-2 · Cited by 100
Caberlotto, L., Jimenez, P., Overstreet, D. H., Hurd, Y. L., Mathé, A. A., & Fuxé, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00234-7 · Cited by 100
Ligand-induced signal transduction within heterodimeric GABA B receptor
Margeta, M., Jan, Y. N., & Jan, L. Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251554798 · Cited by 100
Herman, J. P., Schäfer, M. K.-H., Sladek, C. D., Day, R. W., Young, E. A., Akil, H., & Watson, S. J. (1989) · Brain Research · doi:10.1016/0006-8993(89)90641-0 · Cited by 100
Londborg, P. D., Smith, W. T., Glaudin, V., & Painter, J. R. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00195-0 · Cited by 100
Cloning, After Cloning, Knock-out Mice, and Physiological Functions of MAO A and B
Shih, J. H. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(03)00112-8 · Cited by 100
Masand, P. S., Ashton, A. K., Gupta, S., & Frank, B. L. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.5.805 · Cited by 100
Tabata, T., Araishi, K., Hashimoto, K., Hashimotodani, Y., van der Putten, H., Bettler, B., & Kano, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405387101 · Cited by 100
Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat
Lüttgen, M., Elvander-Tottie, E., Madjid, N., & Ögren, S. O. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.007 · Cited by 100
Lindner, M. D., Hodges, D. B., Hogan, J. B., Orie, A. F., Corsa, J. A., Barten, D. M., Polson, C. T., Robertson, B., Guss, V. L., Gillman, K. W., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056002 · Cited by 100
Vizi, E. S., Zsilla, G., Caron, M. G., & Kiss, J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1506-04.2004 · Cited by 100
Yan, Z. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:203 · Cited by 100
Maruyama, W., Weinstock, M., Youdim, M. B. H., Nagai, M., & Naoi, M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00211-8 · Cited by 100
Convergent evolution of gene networks by single‐gene duplications in higher eukaryotes
Amoutzias, G. D., Robertson, D. L., Oliver, S. G., & Bornberg‐Bauer, E. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400096 · Cited by 100
Corticotropin-releasing hormone (CRH) as a regulator of waking
Chang, F.-C., & Opp, M. R. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00024-0 · Cited by 99
Altered regulation of the 5‐HT system in the brain of MAO‐A knock‐out mice
Evrard, A., Malagié, I., Laporte, A., Boni, C., Hanoun, N., Trillat, A., Seif, I., Maeyer, E. D., Gardier, A. M., Hamon, M., et al. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01917.x · Cited by 99
Pigott, T. A., Hill, J., Grady, T. A., L'Heureux, F., BERNSTEIN, S. E., Rubenstein, C., & Murphy, D. L. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90272-f · Cited by 99
Y1 receptors regulate aggressive behavior by modulating serotonin pathways
Karl, T., Lin, S., Schwarzer, C., Sainsbury, A., Couzens, M., Wittmann, W., Boey, D., von Hörsten, S., & Herzog, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404085101 · Cited by 99
Ebert, D., & Berger, T. (1998) · Psychopharmacology · doi:10.1007/s002130050732 · Cited by 99
Gobert, A., Rivet, J., Cistarelli, L., Melon, C., & Millan, M. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062616.x · Cited by 99
Self-citationTrillat, A., Malagié, I., Scearce-Levie, K., Pons, D., Anmella, M.-C., Jacquot, C., Hen, R., & Gardier, A. M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052019.x · Cited by 99
Pharmacophylogenomics: genes, evolution and drug targets
Searls, D. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1152 · Cited by 99
Involvement of Serotonin and Dopamine in the Mechanism of Action of Novel Antidepressant Drugs
Bonhomme, N., & Esposito, E. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812000-00005 · Cited by 99
Animal Behavioural Studies in the Evaluation of Antidepressant Drugs
Thiébot, M.-H., Martin, P., & Puech, A. J. (1992) · The British Journal of Psychiatry · doi:10.1192/s0007125000296670 · Cited by 99
Duehmke, R. M., Cornblath, D. R., & Hollingshead, J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003726.pub2 · Cited by 99
Distribution of 5-ht5A, 5-ht5B, 5-ht6 and 5-HT7 receptor mRNAs in the rat brain
Kinsey, A. M., Wainwright, A., HEAVENS, R. P., SIRINATHSINGHJI, D. J. S., & Oliver, K. R. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00034-1 · Cited by 98
Lamotrigine as an Augmentation Agent in Treatment-Resistant Depression
Barbee, J. G., & Jamhour, N. J. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0813 · Cited by 98
Hippocampal changes and white matter lesions in early-onset depression
Janssen, J., Pol, H. E. H., Lampe, I. K., Schnack, H. G., de Leeuw, F., Kahn, R. S., & Heeren, T. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.011 · Cited by 98
Zetterström, T., Pei, Q., & Smith, A. D. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00077-1 · Cited by 98
Pramipexole in Routine Clinical Practice: A Prospective Observational Trial in Parkinson??s Disease
Reichmann, H., Brecht, H. M., K??ster, J., Kraus, P. H., & Lemke, M. R. (2003) · CNS Drugs · doi:10.2165/00023210-200317130-00003 · Cited by 98
Weber, E. T., Gannon, R. L., & Rea, M. A. (1998) · Journal of Biological Rhythms · doi:10.1177/074873098129000057 · Cited by 98
5-ht6 Receptors as Emerging Targets for Drug Discovery
Branchek, T. A., & Blackburn, T. P. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.319 · Cited by 98
Estimating Coarse Gene Network Structure from Large-Scale Gene Perturbation DataPreprint
Wagner, A. (2002) · Genome Research · doi:10.1101/gr.193902 · Cited by 98
Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate.
Berrettini, W., Nürnberger, J. I., Hare, T. A., Simmons-Alling, S., Gershon, E. S., & Post, R. M. (1983) · PubMed · Cited by 98
Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set‐shifting
Chen, K. C., Baxter, M. G., & Rodefer, J. S. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03548.x · Cited by 97
Treating generalized anxiety disorder.
Gorman, J. M. (2003) · PubMed · Cited by 97
The dissociation of explicit and implicit memory in depressed patients
Bazin, N., Perruchet, P., de Bonis, M., & Féline, A. (1994) · Psychological Medicine · doi:10.1017/s0033291700027008 · Cited by 97
Itoh, T., Tokumura, M., & Abe, K. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.084 · Cited by 97
Millan, M. J., Brocco, M., Gobert, A., Dorey, G., Casara, P., & Dekeyne, A. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00244-5 · Cited by 97
Self-citationObesity among outpatients with Major Depressive Disorder
Papakostas, G. I., Petersen, T., Iosifescu, D. V., Burns, A. M., Nierenberg, A. A., Alpert, J. E., Rosenbaum, J. F., & D, M. F. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004602 · Cited by 97
Neuropeptide expression in rats exposed to chronic mild stresses
Sergeyev, V., Fetissov, S. O., Mathé, A. A., Jimenez, P. A., Bartfai, T., Mortas, P., Gaudet, L., Moreau, J., & H�kfelt, T. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2015-3 · Cited by 97
Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system
Sanders‐Bush, E., Breeding, M., Knoth, K. M., & Tsutsumi, M. (1989) · Psychopharmacology · doi:10.1007/bf00634454 · Cited by 97
Kopp, C., Vogel, E., Rettori, M., Delagrange, P., & Misslin, R. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199902000-00007 · Cited by 97
Serotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms
Kennaway, D. J., & Moyer, R. W. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00746-x · Cited by 97
Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects
Lal, S., Ackman, D., Thavundayil, J., Kiely, M. E., & Etienke, P. (1984) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(84)90040-x · Cited by 97
LY404187: A Novel Positive Allosteric Modulator of AMPA Receptors
Quirk, J. C., & Nisenbaum, E. S. (2002) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2002.tb00228.x · Cited by 97
μ-Opioid receptors and limbic responses to aversive emotional stimuli
Liberzon, I., Zubieta, J. K., Fig, L. M., Phan, K. L., Koeppe, R. A., & Taylor, S. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102174799 · Cited by 97
Neuropharmacology of Paradoxic Weight Gain with Selective Serotonin Reuptake Inhibitors
Harvey, B. H., & Bouwer, C. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200003000-00006 · Cited by 97
The Metabolic Fate of Amitriptyline, Nortriptyline and Amitriptylinoxide in Man
Breyer-Pfaff, U. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-200033482 · Cited by 97
Korte, S. M., de Kloet, E. R., Buwalda, B., Bouman, S. D., & Bohus, B. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00064-7 · Cited by 97
Characterization of an allosteric citalopram‐binding site at the serotonin transporter
Chen, F., Larsen, M. B., Neubauer, H. A., Sánchez, C., Plenge, P., & Wiborg, O. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02835.x · Cited by 97
Roiser, J. P., McLean, A., Ogilvie, A. D., Blackwell, A. D., Bamber, D. J., Goodyer, I., Jones, P. B., & Sahakian, B. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300659 · Cited by 96
The Non-Antiemetic Uses of Serotonin 5-HT3 Receptor Antagonists
Greenshaw, A. J., & Silverstone, P. H. (1997) · Drugs · doi:10.2165/00003495-199753010-00003 · Cited by 96
Jentsch, J. D., Taylor, J. R., Redmond, D. E., Elsworth, J. D., Youngren, K. D., & Roth, R. H. (1999) · Psychopharmacology · doi:10.1007/s002130050865 · Cited by 96
Female gonadal hormones, serotonin, and sexual receptivity
Uphouse, L. L. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00032-1 · Cited by 96
Sleep deprivation stimulates serotonin release in the suprachiasmatic nucleus
Grossman, G., Mistlberger, R. E., Antle, M. C., Ehlen, J. C., & Glass, J. D. (2000) · Neuroreport · doi:10.1097/00001756-200006260-00024 · Cited by 96
SEROTONIN 5-HT2C RECEPTOR AGONISTS: POTENTIAL FOR THE TREATMENT OF OBESITY
Miller, K. J. (2005) · Molecular Interventions · doi:10.1124/mi.5.5.8 · Cited by 96
Stenfors, C., Theodorsson, E., & Mathé, A. A. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490240315 · Cited by 96
α2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs
Kalkman, H. O., & Loetscher, E. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01308-6 · Cited by 96
Groenink, L., Pattij, T., de Jongh, R., van der Gugten, J., Oosting, R. S., Dirks, A., & Olivier, B. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01281-0 · Cited by 96
Depression increases onset of tension-type headache following laboratory stress
Janke, A. E., Holroyd, K. A., & Romanek, K. M. (2004) · Pain · doi:10.1016/j.pain.2004.06.007 · Cited by 96
Chen, N., & Reith, M. E. A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041585.x · Cited by 96
On the trail of a cognitive enhancer for the treatment of schizophrenia
Stip, É., Chouinard, S., & Boulay, L. J. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.004 · Cited by 96
The origins and implications of Aluternative splicing
Kreahling, J. M. (2003) · Trends in Genetics · doi:10.1016/j.tig.2003.11.001 · Cited by 96
Frisch, C., Dere, E., Silva, M. A. D. S., Gödecke, A., Schrader, J., & Huston, J. P. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06694.2000 · Cited by 96
Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another?
Brown, W. A., & Harrison, W. M. (1995) · PubMed · Cited by 95
Chronic Stress, Depression and Antidepressants: Effects on Gene Transcription in the Hippocampus
Alfonso, J., Frasch, A. C. C., & Flügge, G. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.1.43 · Cited by 95
Discovery and SAR of Org 24598—A Selective Glycine Uptake Inhibitor
Brown, A. R., Carlyle, I., Clark, J., Hamilton, W. D., GIBSON, S. G., McGarry, G., McEachen, S., Rae, D. R., Thorn, S. N., & Walker, G. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00355-9 · Cited by 95
Joyce, J. N., Presgraves, S. P., Renish, L., Borwege, S., Osredkar, T., Hagner, D., Replogle, M., Soldán, M. M. P., & Millan, M. J. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00353-4 · Cited by 95
Self-citationBritton, K. T., Akwa, Y., Spina, M. G., & Koob, G. F. (2000) · Peptides · doi:10.1016/s0196-9781(99)00169-2 · Cited by 95
Silva, R. H., Chehin, A. B., Kameda, S. R., Takatsu-Coleman, A. L., Abílio, V. C., Tufik, S., & Frussa-Filho, R. (2004) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2004.04.005 · Cited by 95
Chalon, S., Granier, L., Vandenhende, F., Bieck, P. R., Bymaster, F. P., Joliat, M. J., Hirth, C., & Potter, W. Z. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300209 · Cited by 95
Response of the Mouse Circadian System to Serotonin 1A/2/7 Agonists in vivo: Surprisingly Little
Antle, M. C., Ogilvie, M. D., Pickard, G. E., & Mistlberger, R. E. (2003) · Journal of Biological Rhythms · doi:10.1177/0748730403251805 · Cited by 95
Vindlacheruvu, R. R., Ebling, F. J. P., Maywood, E. S., & Hastings, M. H. (1992) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1992.tb00176.x · Cited by 95
The circadian system and the therapeutics of the affective disorders
Healy, D. T., & Waterhouse, J. M. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)00077-g · Cited by 95
Citalopram reduces social interaction in rats by activation of serotonin (5-HT)2C receptors
Dekeyne, A., Denorme, B., Monneyron, S., & Millan, M. J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00268-3 · Cited by 95
Self-citationRole of CYP2D6 in the stereoselective disposition of venlafaxine in humans.
Eap, C. B., Lessard, E., Baumann, P., Brawand-Amey, M., Yessine, M., O’Hara, G. E., & Turgeon, J. (2003) · Pharmacogenetics · doi:10.1097/00008571-200301000-00006 · Cited by 95
Steinberg, R., Alonso, R., Griebel, G., Bert, L., Jung, M., Oury-Donat, F., Poncelet, M., Gueudet, C., Desvignes, C., Fur, G. L., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29250-8 · Cited by 95
Pancheri, P., Picardi, A., Pasquini, M., Gaetano, P., & Biondi, M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00328-1 · Cited by 94
O’Hanlon, J. F., Robbe, H. W. J., Vermeeren, A., van Leeuwen, C. J., & Danjou, P. E. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199806000-00006 · Cited by 94
5-Hydroxytryptamine2C receptors on spinal neurons controlling penile erection in the rat.
Bancila, M., Vergé, D., Rampin, O., Backstrom, J., Sanders-Bush, E., Mckenna, K., Marson, L., Calas, A., & Giuliano, F. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00082-2 · Cited by 94
Pharmacogenetics of antipsychotic-induced weight gain
Correll, C. U., & Malhotra, A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1949-9 · Cited by 94
Jones, R. S. G., & Boulton, A. A. (1980) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y80-038 · Cited by 94
Humphrey, P. P. A., Bountra, C., Clayton, N. M., & Kozlowski, K. (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00003.x-i2 · Cited by 94
Astroglial dopamine transport is mediated by norepinephrine transporter
Takeda, H., Inazu, M., & Matsumiya, T. (2002) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-002-0640-0 · Cited by 94
The Multiassembly Problem: Reconstructing Multiple Transcript Isoforms From EST Fragment MixturesPreprint
Xing, Y., Resch, A. M., & Lee, C. J. (2004) · Genome Research · doi:10.1101/gr.1304504 · Cited by 94
The risk factors for depression in first myocardial infarction patients
Dickens, C. M., Percival, C., McGowan, L., Douglas, J. T., Tomenson, B., Cotter, L., Heagerty, A. M., & Creed, F. H. (2004) · Psychological Medicine · doi:10.1017/s0033291704001965 · Cited by 94
Pralong, F. P., Gonzales, C., Voirol, M., Palmiter, R. D., Brunner, H. R., Gaillard, R. C., Seydoux, J., & Pedrazzini, T. (2002) · The FASEB Journal · doi:10.1096/fj.01-0754fje · Cited by 94
Schechter, L. E., Dawson, L. A., & Harder, J. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023396483 · Cited by 94
Ordway, G. A., Gambarana, C., & Frazer, A. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20043-x · Cited by 94
Reeth, O. V., Weibel, L., Olivares, E., Maccari, S., Mocaër, E., & Turek, F. W. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.5.r1582 · Cited by 93
Inhibition of G Protein-Activated Inwardly Rectifying K+ Channels by Various Antidepressant Drugs
Kobayashi, T., Washiyama, K., & Ikeda, K. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300484 · Cited by 93
Smith, B. N., Sollars, P. J., Dudek, F. E., & Pickard, G. E. (2001) · Journal of Biological Rhythms · doi:10.1177/074873040101600104 · Cited by 93
Opposite effects of dopamine D2 and D3 receptors on learning and memory in the rat
Sigala, S., Missale, C., & Spano, P. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01235-1 · Cited by 93
Yang, W., Wang, Q., Kanes, S., Murray, J. M., & Nishikura, K. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.02.010 · Cited by 93
Behavioral and biochemical investigations of bupropion metabolites
Bondarev, M. L., Bondareva, T. S., Young, R., & Glennon, R. A. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02010-7 · Cited by 93
Skene, D. J., Bojkowski, C. J., & Arendt, J. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04258.x · Cited by 93
Davis, R., & Faulds, D. M. (1996) · Drugs · doi:10.2165/00003495-199652050-00007 · Cited by 93
Psychomotor retardation and anhedonia in depression
Lemke, M. R., Puhl, P., Koethe, N., & Winkler, T. (1999) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb07221.x · Cited by 93
Tramadol induces antidepressant-type effects in mice
Rojas-Corrales, M. O., Gibert‐Rahola, J., & Micó, J. A. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00369-5 · Cited by 93
Homo- and hetero-oligomerization of G protein-coupled receptors
Lee, S. P., O’Dowd, B. F., & George, S. R. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.09.028 · Cited by 92
SIRINATHSINGHJI, D. J. S. (1986) · Brain Research · doi:10.1016/0006-8993(86)90957-1 · Cited by 92
Tatarczynska, E., Kłodzińska, A., Kroczka, B., Chojnacka-Wójcik, E., & Pilc, A. (2001) · Psychopharmacology · doi:10.1007/s002130100798 · Cited by 92
Modulation of stress-induced neurobehavioral changes by nitric oxide in rats
Masood, A., Banerjee, B., Vijayan, V. K., & Ray, A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02688-2 · Cited by 92
Argyropoulos, S. V., Hood, S. D., Adrover, M., Bell, C., Rich, A. S., Nash, J. R., Rich, N. C., Witchel, H. J., & Nutt, D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.006 · Cited by 92
Mize, A. L., & Alper, R. H. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01998-3 · Cited by 92
Herrick‐Davis, K., Grinde, E., & Mazurkiewicz, J. E. (2004) · Biochemistry · doi:10.1021/bi048398p · Cited by 92
Direction of Weight Change in Recurrent Depression
Stunkard, A. J. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810210065009 · Cited by 92
Neurologic, Psychological, and Aggressive Disturbances with Sildenafil
Milman, H. A., & Arnold, S. B. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a402 · Cited by 92
Page, M. E., Cryan, J. F., Sullivan, A., Dalvi, A., Saucy, B., Manning, D. R., & Lucki, I. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034280 · Cited by 92
“Broad spectrum” antidepressants: Is more better for the treatment of depression?
Skolnick, P., Popik, P., Janowsky, A. J., Beer, B., & LIPPA, A. S. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.06.007 · Cited by 92
Messenger RNA Editing of the Human Serotonin 5-HT2C Receptor
Fitzgerald, L. W., Iyer, G. S., Conklin, D. S., Krause, C., Marshall, A. M., Patterson, J. P., Tran, D. P., Jonak, G. J., & Hartig, P. R. (1999) · Neuropsychopharmacology · doi:10.1038/sj.npp.1395328 · Cited by 92
Inazu, M., Takeda, H., & Matsumiya, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01566.x · Cited by 91
Bromocriptine and imipramine in endogenous depression
Wæhrens, J., & Gerlach, J. (1981) · Journal of Affective Disorders · doi:10.1016/0165-0327(81)90044-6 · Cited by 91
Yamada, J., Sugimoto, Y., & Yamada, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.09.057 · Cited by 91
Intestinal Absorption of Drugs Mediated by Drug Transporters: Mechanisms and Regulation
Katsura, T., & Inui, K. (2003) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.18.1 · Cited by 91
Antidepressants for the treatment of depression in people with schizophrenia: a systematic review
WHITEHEAD, C., Moss, S., Cardno, A. G., & Lewis, G. (2003) · Psychological Medicine · doi:10.1017/s0033291703007645 · Cited by 91
Dopamine D-5 receptor modulates hippocampal acetylcholine release
Hersi, A. I., Kitaichi, K., Srivastava, L. K., Gaudreau, P., & Quirion, R. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00015-2 · Cited by 91
Angulo, J., Peiró, C., Sánchez‐Ferrer, C. F., Gabancho, S., Cuevas, P., Gupta, S., & de Tejada, I. S. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704351 · Cited by 91
Devoto, P., Flore, G., Pira, L., Longu, G., & Gessa, G. L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.01.018 · Cited by 91
From protein networks to biological systems
Uetz, P., & Finley, R. L. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.001 · Cited by 91
Yoshida, K., Naito, S., Takahashi, H., Sato, K., Ito, K., Kamata, M., Higuchi, H., Shimizu, T., Itoh, K., Inoue, K., et al. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00267-1 · Cited by 91
ska, E. T., ska, A. K. O., Stachowicz, K., & Chojnacka-Wójcik, E. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200412000-00001 · Cited by 91
Ferraro, L., Fuxé, K., Tanganelli, S., Fernández, M., Rambert, F. A., & Antonelli, T. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00019-8 · Cited by 91
Lacroix, L. P., Hows, M. E. P., Shah, A. J., Hagan, J. J., & Heidbreder, C. A. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300114 · Cited by 91
Extra‐cellular dopamine increases in the paraventricular nucleus of male rats during sexual activity
Melis, M. R., Succu, S., Mascia, M. S., Cortis, L., & Argiolas, A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02558.x · Cited by 91
Jiménez-Vasquez, P. A., Overstreet, D. H., & Mathé, A. A. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00036-4 · Cited by 91
Dirks, A., Groenink, L., Bouwknecht, J. A., Hijzen, T. H., van der Gugten, J., Ronken, E., Verbeek, J. S., Veening, J. G., Dederen, P. J. W. C., Kőrösi, A., et al. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02245.x · Cited by 91
Liu, Y., Emeson, R. B., & Samuel, C. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18351 · Cited by 90
M1 muscarinic receptor signaling in mouse hippocampus and cortex
Porter, A. C., Bymaster, F. P., DeLapp, N. W., Yamada, M., Wess, J., Hamilton, S. E., Nathanson, N. M., & Felder, C. C. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02721-x · Cited by 90
Regulation of Gene Expression by Lithium and Depletion of Inositol in Slices of Adult Rat Cortex
Brandish, P. E., Su, M., Holder, D., Hodor, P. G., Szumiloski, J., Kleinhanz, R. R., Forbes, J. E., McWhorter, M., Duenwald, S., Parrish, M. L., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.006 · Cited by 90
Naie, K., & Manahan‐Vaughan, D. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03864.x · Cited by 90
Goodwin, R. D., Stayner, D. A., Chinman, M., Wu, P., Tebes, J. K., & Davidson, L. (2002) · Comprehensive Psychiatry · doi:10.1053/comp.2002.33500 · Cited by 90
NITRIC OXIDE AND GABA A RECEPTOR FUNCTION THE RAT CEREBRAL CORTEX AND CEREBELLAR GRANULE CELLS
Robello, M., Amico, C., Bucossi, G., Cupello, A., Rapallino, M. V., & Thellung, S. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00110-8 · Cited by 90
Monaca, C. C., Boutrel, B., Hen, R., Hamon, M., & Adrien, J. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300109 · Cited by 90
Buspirone treatment of sexual dysfunction associated with selective serotonin re‐uptake inhibitors
Norden, M. J. (1994) · Depression · doi:10.1002/depr.3050020208 · Cited by 90
Devoto, P., Flore, G., Pira, L., Longu, G., & Gessa, G. L. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02239.x · Cited by 90
Miller, D. K., Sumithran, S. P., & Dwoskin, L. P. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033852 · Cited by 90
Lerer, B., & Macciardi, F. M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002936 · Cited by 90
Regulation of corticosteroid receptors in the rat brain: the role of serotonin and stress
Robertson, D. A. F., Beattie, J., Reid, I., & Balfour, D. J. K. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03990.x · Cited by 90
Interaction of zinc with antidepressants in the forced swimming test in mice.
Szewczyk, B., Brański, P., Wierońska, J. M., Pałucha-Poniewiera, A., Pilc, A., & Nowak, G. (2002) · PubMed · Cited by 90
PRINCIPLES AND PRACTICE OF SLEEP MEDICINE
Jones, M. C. (1990) · CHEST Journal · doi:10.1016/s0012-3692(16)32068-2 · Cited by 90
Boothman, L. J., Allers, K. A., Rasmussen, K., & Sharp, T. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705328 · Cited by 89
Inhibition of G protein‐activated inwardly rectifying K+ channels by fluoxetine (Prozac)
Kobayashi, T., Washiyama, K., & Ikeda, K. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705172 · Cited by 89
Maddock, C., Baita, A., Orrù, M. G., Sitzia, R., Costa, A., Muntoni, E., Farci, M. G., Carpiniello, B., & Pariante, C. M. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104040230 · Cited by 89
Kähkönen, S., Komssi, S., Wilenius, J., & Ilmoniemi, R. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2197-3 · Cited by 89
An in situ hybridization study of the distribution of the GABAB2 protein mRNA in the rat CNS
Durkin, M. M., Gunwaldsen, C., Borowsky, B., JONES, K. A., & Branchek, T. A. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00182-5 · Cited by 89
Zill, P., Büttner, A., Eisenmenger, W., Bondy, B., & Ackenheil, M. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.10.002 · Cited by 89
Vasopressin as a target for antidepressant development: an assessment of the available evidence
Scott, L. V., & Dinan, T. G. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00026-5 · Cited by 89
Ventral hippocampal α4β2 nicotinic receptors and chronic nicotine effects on memory
Bancroft, A., & Levin, E. D. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00099-x · Cited by 89
Mallick, B. N., Kaur, S., & Saxena, R. N. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00062-8 · Cited by 89
Hipólide, D. C., Moreira, K. D. M., Barlow, K. B. L., Wilson, A. A., Nóbrega, J. N., & Tufik, S. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.015 · Cited by 89
Prediction of the response to citalopram and reboxetine in post-stroke depressed patients
Rampello, L., Chiechio, S., Nicoletti, G. F., Alvano, A., Vecchio, I., Raffaele, R., & Malaguarnera, M. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1698-1 · Cited by 89
Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates
Willie, J. T., Renthal, W. R., Chemelli, R. M., Miller, M. S., Scammell, T. E., Yanagisawa, M., & Sinton, C. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.10.005 · Cited by 89
Hahn, M. K., Mazei‐Robison, M. S., & Blakely, R. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011270 · Cited by 89
Milligan, G., Ramsay, D., Pascal, G., & Carrillo, J. J. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.09.005 · Cited by 89
Uncoupling of social zeitgebers and diurnal cortisol secretion in clinical depression
Stetler, C., Dickerson, S. S., & Miller, G. E. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.03.003 · Cited by 88
Maggio, R., Scarselli, M., Novi, F., Millan, M. J., & Corsini, G. U. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02038.x · Cited by 88
Self-citationCajochen, C., Kräuchi, K., Mori, D., Graw, P., & Wirz‐Justice, A. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.272.4.r1189 · Cited by 88
Comparative Review of Dopamine Receptor Agonists in Parkinsonʼs Disease
Uitti, R. J., & Ahlskog, J. E. (1996) · CNS Drugs · doi:10.2165/00023210-199605050-00006 · Cited by 88
Patenaude, C., Chapman, C. A., Bertrand, S. S., Congar, P., & Lacaille, J. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049015 · Cited by 88
Antiglucocorticoid drugs in the treatment of depression
Reus, V. I., & Wolkowitz, O. M. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.10.1789 · Cited by 88
Evaluation of the α2C-adrenoceptor as a neuropsychiatric drug target
Scheinin, M., Sallinen, J., & Haapalinna, A. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01016-5 · Cited by 88
Bartlik, B. D., Kaplan, P. M., & Kaplan, H. S. (1995) · Journal of Sex & Marital Therapy · doi:10.1080/00926239508414646 · Cited by 88
Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease
Geula, C., & Darvesh, S. (2004) · Drugs of today · doi:10.1358/dot.2004.40.8.850473 · Cited by 88
Serotonergic targets in depression.
Middlemiss, D. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00116-3 · Cited by 88
Fluoxetine Increases GABAA Receptor Activity through a Novel Modulatory Site
Robinson, R., Drafts, B. C., & Fisher, J. L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044834 · Cited by 88
Sachdev, P. S., McBride, R., Loo, C. K. A., Mitchell, P. M., Malhi, G. S., & Croker, V. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01298-7 · Cited by 88
Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation
Nakayama, K., Sakurai, T., & Katsu, H. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.02.007 · Cited by 88
Truncal Adiposity, Relative Growth Hormone Deficiency, and Cardiovascular Risk
Miller, K. K., Biller, B. M. K., Lipman, J. G., Bradwin, G., Rifai, N., & Klibanski, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0894 · Cited by 88
Vry, J. D., Schreiber, R., Melon, C., Dalmus, M., & Jentzsch, K. R. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.01.004 · Cited by 88
Morcuende, S., Gadd, C. A., Peters, M., Moss, A., Harris, E., Sheasby, A., Fisher, A. S., Felipe, C. D., Mantyh, P. W., Rupniak, N. M. J., et al. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02911.x · Cited by 88
Valentini, V., Frau, R., & Chiara, G. D. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02238.x · Cited by 88
Is antidepressant–benzodiazepine combination therapy clinically more useful?
Furukawa, T. A., Streiner, D. L., & Young, L. T. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00254-8 · Cited by 87
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Millan, M. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 110
- Issue
- 2
- Pages
- 135-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2073570537
- Cited by
- 551
- References
- 3,517
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.